BEAM Beam Therapeutics Inc.

$23.99▼ -1.56% Healthcare Other
After hours $24.12▲ +0.54% Sep 11, 7:58 PM ET
Volume 1.19M Avg Volume (10D) 1.95M
Key Metrics & Fundamentals
Market Cap
$2.48B
P/E Ratio
–
Div Yield
–%
52W Range
20.23 - 38.26
% vs 50 MA
-16.14%
% vs 200 MA
-16.12%
RSI-14
33.3
MACD Histogram
-0.5900
Beta (1Y vs SPY)
2.13
Free Cash Flow
-$68.51M
Gross Rev
$490,000
Gross Profit
$490,000
EBITDA
-$117.08M
COGS
–
Operating Exp
$127.04M
Operating Income
-$126.55M
EBIT
-$126.55M
Pretax Income
-$123.13M
Net Income
-$122.68M
EPS (Diluted)
-1.18
Price & Volume History
Loading chart…
Recent News
Beam Therapeutics (BEAM) Restored AAT Levels. Can BEAM-302 Deliver Clinical Benefit?
Insider Monkey · Sep 10, 2026 11:33 PM
3 Promising Genomics Stocks in the Spotlight in 2026
Zacks · Sep 8, 2026 4:46 PM
Beam Therapeutics Targets Accelerated FDA Approval for Base-Editing Treatment
Benzinga · Sep 8, 2026 1:22 PM
Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026
GlobeNewswire · Sep 8, 2026 10:00 AM
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
GlobeNewswire · Sep 1, 2026 11:00 AM
Beam Therapeutics to Participate in Upcoming September 2026 Investor Conferences
GlobeNewswire · Aug 31, 2026 11:00 AM
Beam Therapeutics (BEAM) Stock May Look Stretched As Sales Expectations Climb
Simply Wall St. · Aug 26, 2026 6:20 AM
4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains
Zacks · Aug 24, 2026 1:59 PM
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 6, 2026 12:00 PM
BEAM's Q2 Loss Wider Than Expected, Revenues Fall Y/Y, Pipeline in Focus
Zacks · Aug 5, 2026 3:10 PM
Financial Overview - Income Statement Quarterly

See BEAM's money flow as a full page

Social Sentiment
Avg +0.70 · 18 posts
NewsDiscussionBeam global is a sleeper
r/wallstreetbets · Jul 22, 2026
The post expresses excitement about Beam Global's technology and future prospects.
positive +0.80
NewsDiscussionWhat if the next AI is genetics?
r/StockMarket · Jun 2, 2026
The post highlights BEAM's role in gene-editing therapies, indicating a positive view.
positive +0.60
NewsDiscussionWhat if the next AI is genetics?
r/stocks · Jun 2, 2026
Mentions BEAM's role in the broader gene-editing landscape.
positive +0.50
DDTradeGAIN in $BEAM
r/wallstreetbets · Dec 4, 2025
The author is pleased with the profit made and considers it a 'good bet', indicating a positive sentiment.
positive +0.80
DDTradeDecade of Losses. I’m fixing it. (YOLO in $BEAM)
r/wallstreetbets · Nov 10, 2025
The author expresses strong optimism and identifies Beam as a key part of their strategy, referencing a 60-80% gain. They also state it is a ‘safe play’.
very_positive +0.80
Page 1 of 4 (18 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙